Prasad Gunasekaran, MD
Interventional Cardiology · Kansas City, KSNPI 1609163336
Payments from drug & device makers
Across 639 payments — averaging $417.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shockwave Medical, Inc$193K
- Philips North America LLC$44K
- Boston Scientific$9K
- Abbott$6K
- Medtronic$5K
- Biotronik Inc.$3K
- plus $7K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Shockwave Medical, Inc | 65 | $192,508 |
| Philips North America LLC | 82 | $44,314 |
| Boston Scientific | 158 | $9,252 |
| Abbott | 90 | $5,930 |
| Medtronic(2 entities) | 45 | $4,691 |
| Biotronik Inc. | 80 | $2,856 |
| Edwards Lifesciences | 23 | $2,132 |
| Abiomed | 29 | $1,591 |
| Medical Device Business Services, Inc. | 6 | $1,416 |
| Penumbra, Inc. | 6 | $382 |
| ZOLL Circulation Inc | 6 | $171 |
| Asahi Intecc USA, Inc. | 2 | $169 |
| Biosense Webster, Inc. | 4 | $154 |
| Amgen | 9 | $152 |
| Cordis US CORP. | 3 | $139 |
| E.r. Squibb & Sons, L.L.C. | 5 | $105 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $69 |
| Pfizer | 4 | $58 |
| Janssen Scientific Affairs, LLC | 1 | $51 |
| Chiesi USA, Inc. | 1 | $50 |
| Ancora Heart, Inc. | 1 | $36 |
| Alnylam Pharmaceuticals Inc. | 2 | $36 |
| Merck | 2 | $33 |
| W. L. Gore & Associates, Inc. | 1 | $21 |
| Lantheus Medical Imaging, Inc. | 1 | $18 |
| Novartis | 1 | $17 |
| AstraZeneca | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Novo Nordisk | 1 | $15 |
| Bayer | 1 | $15 |
| Cardinal Health 200 LLC | 1 | $14 |
| Cardiovascular Systems Inc. | 1 | $13 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
| Baylis Medical Company Inc | 1 | $11 |
How this compares
$266,464 in reported general payments places this provider in the 90th percentile of 55 interventional cardiology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Kansas City
- Peter TadrosKansas City$1.3M
- Mark WileyKansas City$1.3M
- Anthony SpaedyKansas City$527K
- Kamal GuptaKansas City$79K
- Eric HockstadKansas City$38K
- Ashwani MehtaKansas City$37K
- John SerfasKansas City$31K
- Venkat PasnooriKansas City$21K
- Georges HajjKansas City$5K
- Hussam FarhoudWichita$270K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.